Cwm, LLC Staar Surgical CO Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Staar Surgical CO stock. As of the latest transaction made, Cwm, LLC holds 887 shares of STAA stock, worth $21,766. This represents 0.0% of its overall portfolio holdings.

Number of Shares

887

Previous 336 163.99%

Holding current value

$21,766

Previous $16,000 106.25%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$29.97 - $47.42 $16,513 - $26,128	551 Added 163.99%	887 $33,000
Q2 2024 Jul 09, 2024	BUY	$38.07 - $52.25 $2,093 - $2,873	55 Added 19.57%	336 $16,000
Q1 2024 Apr 05, 2024	BUY	$27.67 - $39.61 $1,466 - $2,099	53 Added 23.25%	281 $11,000
Q4 2023 Feb 01, 2024	SELL	$30.6 - $43.78 $8,445 - $12,083	-276 Reduced 54.76%	228 $7,000
Q3 2023 Oct 11, 2023	BUY	$39.39 - $58.12 $14,141 - $20,865	359 Added 247.59%	504 $20,000
Q2 2023 Aug 03, 2023	SELL	$50.45 - $72.82 $3,329 - $4,806	-66 Reduced 31.28%	145 $8,000
Q1 2023 Apr 28, 2023	BUY	$51.25 - $79.34 $4,561 - $7,061	89 Added 72.95%	211 $13,000
Q4 2022 Feb 01, 2023	BUY	$46.82 - $76.2 $1,404 - $2,286	30 Added 32.61%	122 $6,000
Q3 2022 Oct 27, 2022	BUY	$70.55 - $111.58 $4,797 - $7,587	68 Added 283.33%	92 $6,000
Q1 2022 Apr 21, 2022	SELL	$57.98 - $93.5 $1,159 - $1,870	-20 Reduced 45.45%	24 $2,000
Q4 2021 Jan 31, 2022	BUY	$88.02 - $127.79 $3,872 - $5,622	44 New	44 $4,000
Q1 2019 Apr 22, 2019	SELL	$27.81 - $40.78 $444 - $652	-16 Closed	0 $0
Q4 2018 Jan 25, 2019	BUY	$28.91 - $50.0 $462 - $800	16 New	16 $1,000

Others Institutions Holding STAA

# of Institutions

252

Shares Held

47.5M

Call Options Held

427K

Put Options Held

206K

View Full List

About STAAR SURGICAL CO

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.18B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

More about STAA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account